Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload
- PMID: 25901069
- PMCID: PMC4408778
- DOI: 10.1161/CIRCULATIONAHA.115.013894
Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload
Figures
Comment in
-
Response to Schiattarella and Hill.Circulation. 2015 Apr 21;131(16):1447. Circulation. 2015. PMID: 26082962 No abstract available.
Similar articles
-
Inhibition of hypertrophy, per se, may not be a good therapeutic strategy in ventricular pressure overload: other approaches could be more beneficial.Circulation. 2015 Apr 21;131(16):1448-57. doi: 10.1161/CIRCULATIONAHA.114.013895. Circulation. 2015. PMID: 25901070 No abstract available.
-
Cardiac tumour necrosis factor receptor-associated factor 7 mediates the ubiquitination of apoptosis signal-regulating kinase 1 and aggravates cardiac hypertrophy.Cardiovasc Res. 2024 Dec 14;120(16):2031-2046. doi: 10.1093/cvr/cvae217. Cardiovasc Res. 2024. PMID: 39373232
-
Histone deacetylase inhibition has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy.Physiol Res. 2019 Oct 25;68(5):727-737. doi: 10.33549/physiolres.934110. Epub 2019 Aug 19. Physiol Res. 2019. PMID: 31424255
-
Glycogen synthase kinase-3beta -- actively inhibiting hypertrophy.Trends Cardiovasc Med. 2007 Apr;17(3):91-6. doi: 10.1016/j.tcm.2007.01.004. Trends Cardiovasc Med. 2007. PMID: 17418370 Review.
-
Large animal models of pressure overload-induced cardiac left ventricular hypertrophy to study remodelling of the human heart with aortic stenosis.Cardiovasc Res. 2024 Apr 30;120(5):461-475. doi: 10.1093/cvr/cvae045. Cardiovasc Res. 2024. PMID: 38428029 Free PMC article. Review.
Cited by
-
Heart failure-potential new targets for therapy.Br Med Bull. 2016 Sep;119(1):99-110. doi: 10.1093/bmb/ldw025. Epub 2016 Jun 30. Br Med Bull. 2016. PMID: 27365454 Free PMC article. Review.
-
Myeloid MKL1 Disseminates Cues to Promote Cardiac Hypertrophy in Mice.Front Cell Dev Biol. 2021 Apr 9;9:583492. doi: 10.3389/fcell.2021.583492. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33898415 Free PMC article.
-
Klotho attenuates isoproterenol-induced hypertrophic response in H9C2 cells by activating Na+/K+-ATPase and inhibiting the reverse mode of Na+/Ca2+-exchanger.In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):250-256. doi: 10.1007/s11626-017-0215-5. Epub 2018 Jan 17. In Vitro Cell Dev Biol Anim. 2018. PMID: 29344767
-
Epigenetic Regulation in Myocardial Fibroblasts and Its Impact on Cardiovascular Diseases.Pharmaceuticals (Basel). 2024 Oct 10;17(10):1353. doi: 10.3390/ph17101353. Pharmaceuticals (Basel). 2024. PMID: 39458994 Free PMC article. Review.
-
Remodelling of adult cardiac tissue subjected to physiological and pathological mechanical load in vitro.Cardiovasc Res. 2022 Feb 21;118(3):814-827. doi: 10.1093/cvr/cvab084. Cardiovasc Res. 2022. PMID: 33723566 Free PMC article.
References
-
- Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370–80. - PubMed
-
- Hill JA, Olson EN. Muscle: Fundamental Biology and Mechanisms of Disease. 2012:1528.
-
- Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation. 2004;109:1580–9. - PubMed
-
- Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources